Caption Management, LLC Reata Pharmaceuticals Inc Call Options Transaction History

Caption Management, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $35.3 Million - $47 Million	-445,800 Reduced 84.56%	81,400 $8.3 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $16.3 Million - $49.1 Million	527,200 New	527,200 $47.9 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $5.34 Million - $10 Million	275,000 New	275,000 $6.91 Million
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $310,650 - $547,500	-15,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$24.12 - $39.6 $361,800 - $594,000	15,000 New	15,000 $492,000
Q4 2020 Feb 16, 2021	SELL	$102.03 - $184.62 $1.71 Million - $3.1 Million	-16,800 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $168,354 - $294,012	1,800 Added 12.0%	16,800 $1.64 Million
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $7.63 Million - $10.7 Million	-60,400 Reduced 80.11%	15,000 $2.34 Million
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $24,832 - $49,548	200 Added 0.27%	75,400 $10.9 Million
Q4 2019 Feb 13, 2020	BUY	$74.57 - $217.92 $3 Million - $8.76 Million	40,200 Added 114.86%	75,200 $15.4 Million
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $1.78 Million - $2.39 Million	25,000 Added 250.0%	35,000 $2.81 Million
Q2 2019 Aug 13, 2019	BUY	$77.72 - $94.35 $777,200 - $943,500	10,000 New	10,000 $943,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.